Your browser doesn't support javascript.
loading
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer.
Hannan, Raquibul; Christensen, Michael; Hammers, Hans; Christie, Alana; Paulman, Brendan; Lin, Dandan; Garant, Aurelie; Arafat, Waddah; Courtney, Kevin; Bowman, Isaac; Cole, Suzanne; Sher, David; Ahn, Chul; Choy, Hak; Timmerman, Robert; Brugarolas, James.
Afiliación
  • Hannan R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Raquibul.Hannan@utsouthwestern.edu.
  • Christensen M; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Hammers H; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Christie A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Paulman B; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Lin D; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Garant A; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Arafat W; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Courtney K; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Bowman I; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Cole S; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Sher D; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Ahn C; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Choy H; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Timmerman R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Robert.Timmerman@utsouthwestern.edu.
  • Brugarolas J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: James.Brugarolas@utsouthw
Eur Urol Oncol ; 5(2): 216-224, 2022 04.
Article en En | MEDLINE | ID: mdl-34986993

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Radiocirugia / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Límite: Female / Humans / Male Idioma: En Revista: Eur Urol Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Radiocirugia / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Límite: Female / Humans / Male Idioma: En Revista: Eur Urol Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos